SANTANDER UK PLC
PUBLICATION OF LISTING PROSPECTUS
The following listing prospectus (the Prospectus) has been approved by the UK Financial Conduct Authority and is available for viewing:
Listing Prospectus dated 26 November 2024 (the Prospectus) relating to Multiple Series of Equity Index Linked Notes previously issued and outstanding under the Notes and Certificate Programme of Santander UK plc, as listed in the table below (together, the Notes).
| Description
| ISIN |
| Series 1136 Issue of GBP 8,930,112 Equity Index Linked Notes due 30 December 2024 | XS1866007542 |
| Series 1139 Issue of GBP 22,107,629 Equity Index Linked Notes due 25 February 2025 | XS1894675914 |
| Series 1141 Issue of GBP 4,623,772 Equity Index Linked Notes due 23 April 2025 | XS1917956440 |
| Series 1144 Issue of GBP 18,940,809 Equity Index Linked Notes due 10 June 2025 | XS1939334675 |
| Series 1149 Issue of GBP 7,525,095 Equity Index Linked Notes due 12 August 2025 | XS1970465974 |
| Series 1151 Issue of £6,907,632 Equity Index Linked Notes due October 2025 | XS2005531103 |
| Series 1155 Issue of £4,472,715 Equity Index Linked Notes due December 2025 | XS2035095459 |
| Series 1158 Issue of £7,027,790 Equity Index Linked Notes due January 2026 | XS2063664275 |
| Series 1160 £4,511,380 Equity Index Linked Notes due March 2026 | XS2085849870 |
| Series 1166 Issue of GBP 4,177,216 Equity Index Linked Notes due May 2026 | XS2101558992 |
| Series 1170 Issue of £3,856,994 Equity Index Linked Notes due July 2026 | XS2133252218 |
| Series 1172 Issue of £4,635,447 Equity Index Linked Notes due July 2026 | XS2159802359 |
| Series 1174 Issue of GBP 30,000,000 Equity Index Linked Notes due September 2026 | XS2186175571 |
| Series 1176 Issue of £13,225,540 Equity Index Linked Notes due November 2026 | XS2196322585 |
| Series 1178 Issue of £15,636,746 Equity Index Linked Notes due December 2026 | XS2222052719 |
| Series 1180 Issue of £39,381,201 Equity Index Linked Notes due February 2027 | XS2238784826 |
| Series 1182 Issue of £1,558,439 Equity Index Linked Notes due March 2027 | XS2262949378 |
| Series 1184 £2,834,541 Equity Index Linked Notes due June 2027 | XS2294359141 |
| Series 1186 £2,247,346 Equity Index Linked Notes due July 2027 | XS2326318990 |
| Series 1188 £1,901,665 Equity Index Linked Notes due August 2027 | XS2352402544 |
The Prospectus has been published in order for the Notes, which are currently admitted to trading on the regulated market of Euronext Dublin, to be admitted to the official list of the FCA and admitted to trading on the London Stock Exchange's Main Market (the London Admission). The London Admission is expected to occur on or around 29 November 2024.
It is the Issuer's intention to delist the Notes from the regulated market of Euronext Dublin shortly after the London Admission becomes effective.
To view the full Prospectus please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/7412N_1-2024-11-26.pdf
A copy of the Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Prospectus will also be available for viewing via:
For further information, please contact:
Structured Notes Desk
Tel: +44 (0) 20 7756 7000 or structurednotesafm@santander.co.uk.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries only (as specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from such Prospectus whether or not you are part of the intended addressees of the information contained therein.
This publication of the Prospectus does not constitute an offer of securities for sale in the United States. The securities described in the Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in the United States of America or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.
Your right to access this service is conditional upon your compliance with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
